Michael S. Weiss, Chairman and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), sold 10,000 shares at $11.58 ($116K) on 2006-07-18, disclosed to the SEC on 2006-07-19.
Scheduled sale ($116k) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.41 | 1,000 | $11K | 9.8% |
| 2 | $11.44 | 600 | $7K | 5.9% |
| 3 | $11.50 | 1,000 | $12K | 9.9% |
| 4 | $11.51 | 1,000 | $12K | 9.9% |
| 5 | $11.58 | 1,500 | $17K | 15.0% |
| 6 | $11.60 | 1,000 |
| $12K |
| 10.0% |
| 7 | $11.70 | 1,400 | $16K | 14.1% |
| 8 | $11.76 | 1,500 | $18K | 15.2% |
| 9 | $11.82 | 1,000 | $12K | 10.2% |
| Total | $11.61 avg | 10,000 | $116K | 100% |
| Filing → |
| FBIO | BUY | 2023-02-14 | $2.0M | — | Filing → |
| TGTX | SELL | 2022-01-07 | $2.6M | — | Filing → |
| TGTX | BUY | 2019-06-27 | $352K | — | Filing → |